1. Home
  2. ASLE vs SNY Comparison

ASLE vs SNY Comparison

Compare ASLE & SNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AerSale Corporation

ASLE

AerSale Corporation

HOLD

Current Price

$6.15

Market Cap

296.8M

ML Signal

HOLD

Logo Sanofi ADS

SNY

Sanofi ADS

HOLD

Current Price

$46.81

Market Cap

107.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASLE
SNY
Founded
2008
1994
Country
United States
France
Employees
N/A
74846
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
296.8M
107.3B
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
ASLE
SNY
Price
$6.15
$46.81
Analyst Decision
Hold
Buy
Analyst Count
2
5
Target Price
$7.00
$58.00
AVG Volume (30 Days)
290.8K
3.7M
Earning Date
03-05-2026
04-23-2026
Dividend Yield
N/A
3.43%
EPS Growth
63.64
N/A
EPS
0.18
N/A
Revenue
$335,286,000.00
N/A
Revenue This Year
$23.41
$3.01
Revenue Next Year
$6.80
$5.80
P/E Ratio
$34.44
$6.14
Revenue Growth
N/A
N/A
52 Week Low
$5.56
$43.32
52 Week High
$9.08
$55.77

Technical Indicators

Market Signals
Indicator
ASLE
SNY
Relative Strength Index (RSI) 30.61 58.78
Support Level $6.05 $45.20
Resistance Level $6.17 $48.97
Average True Range (ATR) 0.15 0.76
MACD -0.00 0.37
Stochastic Oscillator 12.35 77.94

Price Performance

Historical Comparison
ASLE
SNY

About ASLE AerSale Corporation

AerSale Corp offers full-service support to owners and operators of mid-life commercial aircraft. It specializes in the sale, lease, and exchange of used aircraft, engines, and components, in addition to providing various maintenance, repair, and overhaul, and engineering services for commercial aircraft and components. AerSale also offers asset management services to owners of end-of-life aircraft and engine portfolios. The company has two reportable segments: Asset Management Solutions and TechOps. Maximum revenue is generated from the Asset Management Solutions segment, which comprises activities to extract value from strategic asset acquisitions through leasing, trading, or disassembling for product sales. Geographically, the company derives maximum revenue from its domestic market.

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.

Share on Social Networks: